Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3TVJ

Catalytic fragment of MASP-2 in complex with its specific inhibitor developed by directed evolution on SGCI scaffold

Summary for 3TVJ
Entry DOI10.2210/pdb3tvj/pdb
Related4DJZ
DescriptorMannan-binding lectin serine protease 2 A chain, Mannan-binding lectin serine protease 2 B chain, Protease inhibitor SGPI-2, ... (5 entities in total)
Functional Keywordsin vitro evolution, specific inhibitor, allostery, hydrolase
Biological sourceHomo sapiens (human)
More
Cellular locationSecreted: O00187 O00187 O46162
Total number of polymer chains3
Total formula weight39876.91
Authors
Heja, D.,Harmat, V.,Dobo, J.,Szasz, R.,Kekesi, K.A.,Zavodszky, P.,Gal, P.,Pal, G. (deposition date: 2011-09-20, release date: 2012-04-25, Last modification date: 2023-09-13)
Primary citationHeja, D.,Harmat, V.,Fodor, K.,Wilmanns, M.,Dobo, J.,Kekesi, K.A.,Zavodszky, P.,Gal, P.,Pal, G.
Monospecific Inhibitors Show That Both Mannan-binding Lectin-associated Serine Protease-1 (MASP-1) and -2 Are Essential for Lectin Pathway Activation and Reveal Structural Plasticity of MASP-2.
J.Biol.Chem., 287:20290-20300, 2012
Cited by
PubMed Abstract: The lectin pathway is an antibody-independent activation route of the complement system. It provides immediate defense against pathogens and altered self-cells, but it also causes severe tissue damage after stroke, heart attack, and other ischemia reperfusion injuries. The pathway is triggered by target binding of pattern recognition molecules leading to the activation of zymogen mannan-binding lectin-associated serine proteases (MASPs). MASP-2 is considered as the autonomous pathway-activator, while MASP-1 is considered as an auxiliary component. We evolved a pair of monospecific MASP inhibitors. In accordance with the key role of MASP-2, the MASP-2 inhibitor completely blocks the lectin pathway activation. Importantly, the MASP-1 inhibitor does the same, demonstrating that MASP-1 is not an auxiliary but an essential pathway component. We report the first Michaelis-like complex structures of MASP-1 and MASP-2 formed with substrate-like inhibitors. The 1.28 Å resolution MASP-2 structure reveals significant plasticity of the protease, suggesting that either an induced fit or a conformational selection mechanism should contribute to the extreme specificity of the enzyme.
PubMed: 22511776
DOI: 10.1074/jbc.M112.354332
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.28 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon